Single-active enteric functional pellet designed for oxygen and moisture sensitivity an...
Single-active stability-protected ir pellet designed for light, oxygen and heat sensiti...
Single-active stability-protected ir pellet designed for oxidation, light and heat sens...
Single-active enteric oil pellet designed for volatility, odour, oil leakage and gastri...
Single-active taste- and odour-masked ir pellet designed for strong sulphur taste and o...
Single-active taste- and odour-masked ir pellet designed for strong taste, fishy odour,...
Single-active taste-masked and interaction-protected ir pellet designed for metallic ta...
Single-active taste-masked ir pellet designed for strong bitterness and metallic taste ...
Single-active release-modified functional pellet designed for reproducible four-hour su...
Single-active release-modified functional pellet designed for reproducible eight-hour s...
Single-active release-modified functional pellet designed for reproducible four-hour su...
Single-active immediate-release functional pellet designed for high active loading and ...
Formulator’s buyer guide
Functional pellets are multiparticulate ingredients designed around a defined release, protection or sensory objective. NexaGens supplies immediate-release, sustained-release, enteric, stability-protected, and taste- or odour-masked options for B2B formulation evaluation.
Selection should begin with the required release behaviour and finished dosage form. The coating system, active loading, particle-size target, process conditions and evidence package must be assessed together; a pellet format alone does not demonstrate a particular performance result.
Choose the release profile from the intended site and timing of release: immediate release, sustained release over a defined period, or enteric and intestinal delivery.
Protected immediate-release pellets are not automatically sustained release, while taste masking does not by itself imply delayed release. Define the target profile first, then verify product-specific release or dissolution data under relevant test conditions.
The portfolio addresses controlled release, enteric protection, taste and odour masking, environmental stability and powder-handling requirements.
Match the technical objective to the active and dosage form. Sustained-release caffeine, enteric NADH or peppermint oil, taste-masked mineral and amino-acid pellets, and protected immediate-release actives require different validation approaches.
Modified release Enteric and intestinal delivery Taste and odour masking Stability protection
Available formats include caffeine IR, SR-4 and SR-8; enteric NADH and peppermint oil; protected immediate-release astaxanthin and coenzyme Q10; and taste- or odour-masked ingredients.
The supplied technical workbook gives a 500–850 µm target for the pellet range, subject to the current finished-product specification. Review size distribution and blend compatibility for the intended capsule, sachet, tablet or other application before scale-up.
Buyers should review assay, particle-size specification and product-specific release, dissolution, sensory or stability evidence according to the claimed function.
The core approval package should include the current technical data sheet, finished-product specification and batch Certificate of Analysis. Also request the applicable composition, microbiological, heavy-metals, allergen, GMO, storage and regulatory documents. Finished-product suitability and market compliance remain the customer’s responsibility.
Not every ingredient is available in every format. These links go to the other delivery-format collections so you can check what else is available — they do not imply the technologies are equivalent or interchangeable.